BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 28194668)

  • 1. Value of Raw Rhubarb Solution in the Precaution of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis in Patients with High-Risk Factors: A Predictive Random Compared Research in One Center.
    Wang C; Li Q; Ye P; Zeng S; Li GH; Chen YX; Zhou XJ; Lv NH
    Dig Dis Sci; 2017 Apr; 62(4):1043-1050. PubMed ID: 28194668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is prophylactic somatostatin effective to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis or hyperamylasemia? A randomized, placebo-controlled pilot trial.
    Wang ZK; Yang YS; Cai FC; Wang YH; Shi XL; Ding C; Li W
    Chin Med J (Engl); 2013 Jul; 126(13):2403-8. PubMed ID: 23823808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
    Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
    World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.
    Christoforidis E; Goulimaris I; Kanellos I; Tsalis K; Demetriades C; Betsis D
    Endoscopy; 2002 Apr; 34(4):286-92. PubMed ID: 11932783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive hydration with lactated Ringer's solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography.
    Buxbaum J; Yan A; Yeh K; Lane C; Nguyen N; Laine L
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):303-7.e1. PubMed ID: 23920031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia: A systematic review and meta-analysis.
    Wang G; Xiao G; Xu L; Qiu P; Li T; Wang X; Wen P; Wen J; Xiao X
    Pancreatology; 2018 Jun; 18(4):370-378. PubMed ID: 29550097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for post-ERCP pancreatitis and hyperamylasemia: A retrospective single-center study.
    He QB; Xu T; Wang J; Li YH; Wang L; Zou XP
    J Dig Dis; 2015 Aug; 16(8):471-8. PubMed ID: 25955444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
    Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
    Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between ulinastatin and nafamostat for prevention of post-endoscopic retrograde cholangiopancreatography complications: a prospective, randomized trial.
    Park JY; Jeon TJ; Hwang MW; Sinn DH; Oh TH; Shin WC; Choi WC
    Pancreatology; 2014; 14(4):263-7. PubMed ID: 25062874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Somatostatin and Indomethacin Mono or Combination Therapy on High-risk Hyperamylasemia and Post-pancreatitis Endoscopic Retrograde Cholangiopancreatography Patients: A Randomized Study.
    Wu Z; Xiao G; Wang G; Xiong L; Qiu P; Tan S
    Surg Laparosc Endosc Percutan Tech; 2023 Oct; 33(5):474-479. PubMed ID: 37523580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of painless pancreatitis by computed tomography in patients with post-endoscopic retrograde cholangiopancreatography hyperamylasemia.
    Uchino R; Sasahira N; Isayama H; Tsujino T; Hirano K; Yagioka H; Hamada T; Takahara N; Miyabayashi K; Mizuno S; Mohri D; Sasaki T; Kogure H; Yamamoto N; Nakai Y; Tada M; Koike K
    Pancreatology; 2014; 14(1):17-20. PubMed ID: 24555974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-ERCP infusion of semapimod, a mitogen-activated protein kinases inhibitor, lowers post-ERCP hyperamylasemia but not pancreatitis incidence.
    van Westerloo DJ; Rauws EA; Hommes D; de Vos AF; van der Poll T; Powers BL; Fockens P; Dijkgraaf MG; Bruno MJ
    Gastrointest Endosc; 2008 Aug; 68(2):246-54. PubMed ID: 18455169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis.
    Milewski J; Rydzewska G; Degowska M; Kierzkiewicz M; Rydzewski A
    World J Gastroenterol; 2006 Jun; 12(23):3751-5. PubMed ID: 16773694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic somatostatin can reduce incidence of post-ERCP pancreatitis: multicenter randomized controlled trial.
    Bai Y; Ren X; Zhang XF; Lv NH; Guo XG; Wan XJ; Nie ZG; Han ST; Bie P; Tian DA; Ji M; Li ZS
    Endoscopy; 2015 May; 47(5):415-20. PubMed ID: 25590178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study.
    Fujishiro H; Adachi K; Imaoka T; Hashimoto T; Kohge N; Moriyama N; Suetsugu H; Kawashima K; Komazawa Y; Ishimura N; Ishihara S; Amano Y; Kinoshita Y
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1065-9. PubMed ID: 16724996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasobiliary drainage after endoscopic papillary balloon dilatation may prevent postoperative pancreatitis.
    Xu XD; Dai JJ; Qian JQ; Wang WJ
    World J Gastroenterol; 2015 Feb; 21(8):2443-9. PubMed ID: 25741153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ionic, monomer, high osmolar contrast media with non-ionic, dimer, iso-osmolar contrast media in ERCP.
    Ogawa M; Kawaguchi Y; Kawashima Y; Mizukami H; Maruno A; Ito H; Mine T
    Tokai J Exp Clin Med; 2013 Sep; 38(3):109-13. PubMed ID: 24030487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of qingyi decoction in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia].
    Liu CG; Leng DY; Liu H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Jul; 29(7):607-10. PubMed ID: 19852292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Iodixanol Prevent Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis? A Prospective, Randomized, Controlled Trial.
    Ogura T; Imoto A; Okuda A; Fukunishi S; Higuchi K
    Dig Dis; 2019; 37(3):255-261. PubMed ID: 30654370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.